BMS 100 mg 3623 (Reyataz 100 mg)
Generic Name: atazanavir
Pill with imprint BMS 100 mg 3623 is Blue & White, Capsule-shape and has been identified as Reyataz 100 mg. It is supplied by Bristol-Myers Squibb.
Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 100 mg 3623
Reyataz
- Generic Name
- atazanavir
- Imprint
- BMS 100 mg 3623
- Strength
- 100 mg
- Color
- Blue & White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-3623 (Discontinued)
- Inactive Ingredients
-
crospovidone,
lactose monohydrate,
magnesium stearate,
gelatin,
FD&C Blue No. 2,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
isopropyl alcohol,
ammonia,
propylene glycol,
butyl alcohol,
alcohol,
ferrosoferric oxide,
shellac
Note: Inactive ingredients may vary.
More about Reyataz (atazanavir)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2)
- Drug images
- Pricing & coupons
- Generic availability
- En español
- Drug class: protease inhibitors
Patient resources
- Drug Information
- Reyataz (Advanced Reading)
- Reyataz (Atazanavir Capsules)
- Reyataz (Atazanavir Powder for Oral Suspension)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.